Deciphering the etiologies of adult erythroderma: an updated guide to presentations, diagnostic tools, pathophysiologies, and treatments

Y Pang, WQ Nguyen, LI Guerrero, LP Chrisman… - American Journal of …, 2024 - Springer
Erythroderma, an inflammatory skin condition characterized by widespread erythema with
variable degrees of exfoliation, pustulation, or vesiculobullous formation, is associated with …

Treatment options for juvenile Pityriasis Rubra pilaris

J Guenther, D Novack, S Kamath, S Worswick - Pediatric Drugs, 2023 - Springer
Pityriasis rubra pilaris represents a group of familial and acquired disorders of cornification
that affect both adult and pediatric patients. Treatment options are difficult to assess through …

Targeting IL-1 controls refractory pityriasis rubra pilaris

E Schmauch, Y Severin, X Xing, A Mangold… - Science …, 2024 - science.org
Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease with a poorly understood
pathogenesis. Through a molecularly driven precision medicine approach and an extensive …

[PDF][PDF] Pityriasis rubra pilaris transcriptomics implicate T helper 17 signaling and correlate with response to ixekizumab, with distinct gene expression profiles in …

D Haynes, T Reiter, R Velasco, M Chang… - Journal of Investigative …, 2023 - Elsevier
Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disorder associated with significant
patient morbidity (Eastham et al., 2019, Ji-Xu et al., 2022). Recent discoveries in the …

Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review

S Sood, E Akuffo-Addo, J Yeung… - Journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review
Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review J …

Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options

TP Joshi, M Duvic - American Journal of Clinical Dermatology, 2024 - Springer
Pityriasis rubra pilaris (PRP) is a rare papulosquamous reaction pattern with a significant
impact on quality of life. Type I PRP is the most common PRP variant, presenting as …

[HTML][HTML] The effectiveness of anti-interleukin-17A treatment for pityriasis rubra pilaris: A systematic review

M Abduljawad, TH Alsharif, AG Gronfula, TK Magadmi… - Cureus, 2023 - ncbi.nlm.nih.gov
Abstract Anti-interleukin-17A (anti-IL-17A) therapy has been increasingly employed as a
treatment option for pityriasis rubra pilaris (PRP). In this study, we reviewed all available …

Methotrexate and acitretin in pityriasis rubra pilaris: A retrospective cohort study

JD Greenzaid, ML Hrin, SR Feldman… - Journal of the American …, 2024 - Elsevier
To the Editor: Pityriasis rubra pilaris (PRP) is a rare inflammatory cutaneous disorder.
Although biologics are effective for PRP, 1 their high costs can hinder access. Efficacy data …

[HTML][HTML] Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris

L Potestio, M D'Agostino, A Portarapillo, V Esposito… - Life, 2024 - mdpi.com
Pityriasis rubra pilaris (PRP) is a rare, papulosquamous, inflammatory skin disease. PRP
represents a therapeutic challenge. The rarity of this disease and its possible spontaneous …

[HTML][HTML] Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature

M Starace, S Cedirian, F Quadrelli, T Brunetti… - Medicina, 2024 - mdpi.com
Pityriasis rubra pilaris (PRP) presents a diagnostic challenge due to its varied clinical
manifestations and the scarce literature on scalp involvement. This article presents a case …